These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 8723603)

  • 1. Nonlipid primary and secondary prevention strategies for coronary heart disease.
    Maron DJ
    Clin Cardiol; 1996 May; 19(5):419-23. PubMed ID: 8723603
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current therapies for secondary prevention after myocardial infarction.
    Cannon CE; Smith SC
    Curr Opin Cardiol; 1999 Mar; 14(2):155-60. PubMed ID: 10191975
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Secondary prevention of ischaemic cardiac events.
    Gami A
    Clin Evid; 2006 Jun; (15):195-228. PubMed ID: 16973010
    [No Abstract]   [Full Text] [Related]  

  • 4. [Secondary prevention in chronic coronary heart disease].
    Hunziker P; Bertel O
    Schweiz Med Wochenschr; 1997 Feb; 127(7):254-60. PubMed ID: 9157530
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk factors and secondary prevention in women with heart disease: the Heart and Estrogen/progestin Replacement Study.
    Vittinghoff E; Shlipak MG; Varosy PD; Furberg CD; Ireland CC; Khan SS; Blumenthal R; Barrett-Connor E; Hulley S;
    Ann Intern Med; 2003 Jan; 138(2):81-9. PubMed ID: 12529088
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Recommendations for secondary prevention of the clinical coronary cardiopathy].
    Rev Esp Cardiol; 1985; 38(1):14-20. PubMed ID: 2858911
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimal medical management of peripheral arterial disease.
    Rice TW; Lumsden AB
    Vasc Endovascular Surg; 2006; 40(4):312-27. PubMed ID: 16959725
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Secondary prevention of coronary heart disease. How effective are modern therapy methods?].
    Kolenda KD
    Dtsch Med Wochenschr; 2003 Sep; 128(36):1849-53. PubMed ID: 12964107
    [No Abstract]   [Full Text] [Related]  

  • 9. [Secondary prevention of coronary heart disease].
    von Schacky C
    MMW Fortschr Med; 2003 Mar; 145(13):28, 30, 32-3. PubMed ID: 15101529
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Primary and secondary prevention of myocardial infarction.
    Borghi C; Ambrosioni E
    Clin Exp Hypertens; 1996; 18(3-4):547-58. PubMed ID: 8743042
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Treatment after myocardial infarction].
    Beurrier D; Danchin N
    Presse Med; 1994 Feb; 23(8):380-4. PubMed ID: 7911570
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Secondary prevention in coronary heart disease: baseline survey of provision in general practice.
    Campbell NC; Thain J; Deans HG; Ritchie LD; Rawles JM
    BMJ; 1998 May; 316(7142):1430-4. PubMed ID: 9572757
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Conservative treatment of coronary heart disease--current options].
    Desch S; Schuler G; Niebauer J
    MMW Fortschr Med; 2005 Feb; 147(8):45-7. PubMed ID: 18437860
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Survival prospects after acute myocardial infarction in the UK: a matched cohort study 1987-2011.
    Gitsels LA; Kulinskaya E; Steel N
    BMJ Open; 2017 Jan; 7(1):e013570. PubMed ID: 28119386
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The treatment of myocardial infarction.
    Timmis GC; Terrien E
    J Interv Cardiol; 1995 Dec; 8(6 Suppl):730-51. PubMed ID: 10159764
    [No Abstract]   [Full Text] [Related]  

  • 16. Changes in Medical Therapy and Lifestyle After Anatomical or Functional Testing for Coronary Artery Disease.
    Ladapo JA; Hoffmann U; Lee KL; Coles A; Huang M; Mark DB; Dolor RJ; Pelberg RA; Budoff M; Sigurdsson G; Severance HW; Douglas PS
    J Am Heart Assoc; 2016 Oct; 5(10):. PubMed ID: 27733347
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of postmyocardial infarction in the elderly patient.
    Forman R; Aronow WS
    Clin Geriatr Med; 1996 Feb; 12(1):169-80. PubMed ID: 8653656
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Primary and secondary prevention of myocardial infarction and strokes: an update of randomly allocated, controlled trials.
    Yusuf S; Lessem J; Jha P; Lonn E
    J Hypertens Suppl; 1993 Jun; 11(4):S61-73. PubMed ID: 8104243
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Choosing the most appropriate treatment for stable angina. Safety considerations.
    Asirvatham S; Sebastian C; Thadani U
    Drug Saf; 1998 Jul; 19(1):23-44. PubMed ID: 9673856
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Changes in parameters of coagulation system after treatment of chronic heart failure with β-adrenoblockers, angiotensin-converting enzyme inhibitors, calcium antagonists, diuretics, anticoagulants, antiagregants, cardiac glycosides, and physical exercise].
    Mongirdienė A
    Medicina (Kaunas); 2011; 47(4):238-43. PubMed ID: 21829057
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.